.
MergerLinks Header Logo

New Deal


Announced

Antech Diagnostics to acquire EUROLyser from ArchiMed.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

testing services

Acquisition

Private Equity

Austria

Majority

Single Bidder

Cross Border

Private

Friendly

Medical Equipment

diagnostic equipment

Test Inspection and Certification (TIC)

blood testing products

Pending

Synopsis

Edit

Antech Diagnostics, a provider of veterinary care services, agreed to acquire EUROLyser, a provider of point-of-care testing products, from ArchiMed, an investment firm. Financial terms were not disclosed. “ArchiMed knew exactly what we needed to not let opportunities slip by. The partnership with Antech is an example of this," Michael Gruber, EUROLyser Co-Founder and CEO.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US